You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company believes the pandemic will accelerate the adoption of its cancer diagnostics as patients and doctors look for faster and more convenient tests.
The company plans to use the funds to improve patient engagement and navigation within its Genome Care Delivery technology platform.
The diagnostics firm is conducting a 1,000-person study to find T cell profiles associated with the immune response to COVID-19 and recovery from the disease.
The company saw orders for its Cologuard colorectal cancer test fall 63 percent during the first 20 days of April because of a decline in standard healthcare visits.
Ongoing Scripps research into polygenic risk for coronary artery disease now offers remote genetic counseling as well as an Android app.
InformedDNA's network of remote counselors will augment the AI-driven chatbots offered by OptraHealth's automated GeneFax platform.
Cancer centers now can schedule telehealth consultations and receive post-visit reports for high-risk patients through the CancerIQ platform.
With $46 million in total raised since its founding in 2016, the company hopes to scale its telegenetics services to meet national demand.
Vendors look to augment, not replace, genetic counselors with consumer-friendly technology, including AI-driven online chats and decision support systems.
By partnering with telehealth provider PWNHealth, Lineagen wants to help children on the autism spectrum start treatment faster and qualify for more benefits.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.